Research & Studies
Share your love
VSY Biotechnology to Introduce a Novel Anti-VEGF for AMD
VSY Biotechnology GmbH is proud to announce the groundbreaking development of Varliciment, a revolutionary anti-VEGF agent for the treatment of age-related macular degeneration (AMD). Varliciment distinguishes itself from existing anti-VEGF agents like brolucizumab, namely Novartis’ Beovu, by being non-generic. This…
World’s First Whole-Eye and Face Transplant Breakthrough
In a groundbreaking medical feat, a surgical team comprising more than 140 clinicians, including surgeons, nurses, and various healthcare professionals from New York University (NYU) Langone Health, has successfully conducted the world’s first whole-eye and partial face transplantation on a…
AMD Forecast: New Algorithm Offers 94% Accuracy
Researchers at Duke University have developed a computer program that can predict with 94% accuracy whether an individual’s age-related macular degeneration (AMD) will deteriorate within a year. The deep learning algorithm, featured in an article within JAMA Ophthalmology, evaluates comprehensive…
Blind Canvas Project by Ora and BlindCAN Film Festival
Ora and the BlindCAN Film Festival have jointly unveiled The Blind Canvas Project, an initiative that leverages the capabilities of storytelling and generative artificial intelligence (AI) to cultivate a more profound comprehension of the lives and narratives of individuals affected…
Ocular Therapeutix Gets FDA Agreement for Wet AMD Trial
Ocular Therapeutix has obtained written FDA approval for the comprehensive design of its pivotal phase 3 clinical trial, known as the SOL trial, which evaluates Axpaxli (axitinib intravitreal implant) for treating wet age-related macular degeneration (AMD) under a Special Protocol…
FDA Greenlights Phase 1 Trial for IOPCL Magnifier
OnPoint Vision has officially received FDA approval for their investigational device exemption (IDE) application, initiating the phase 1 in the pivotal clinical trial for the AccuraSee Intraocular Pseudophakic Capsular Lens (IOPCL) Magnifier (MAG). This trial focuses on the secondary implantation…
What Is Idiopathic Multifocal Choroiditis and How to Manage It|OBN
What Is Idiopathic Multifocal Choroiditis? Idiopathic Multifocal Choroiditis (IMFC) is a rare eye condition that primarily affects the choroid, a vascular layer situated between the retina and the sclera (the white part of the eye). The condition is characterized by…
Large-Scale Study Sheds Light on Rare Eye Disorders
Researchers have analyzed image and genomic data from the UK Biobank to find insights into rare diseases of the human eye. These include retinal dystrophies – a group of inherited disorders affecting the retina – which are also the leading…
What Is Leber Congenital Amaurosis?
Leber Congenital Amaurosis (LCA) is a rare genetic disorder that affects the retina, the part of the eye responsible for sensing light and sending visual signals to the brain. It is a severe form of retinal dystrophy, which means that…
Dysphotopsia: Causes, Symptoms, Treatment | OBN
What Is Dysphotopsia? Dysphotopsia, a term often sending shivers down the spine of even the most experienced ophthalmologists, refers to a spectrum of visual disturbances that patients may experience following cataract surgery. It is derived from the Greek words ‘dys’…